Skip to main content
Skip to main content
HAPP logo

Happiness Development Group Limited (HAPP) Stock Analysis

DELISTED 2023

What happened to Happiness Development Group Limited (HAPP) stock?

Happiness Development Group Limited (HAPP) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.

MCap: $31.3M| Vol: 1.5K| 52-wk range: $2.08 – $7.40
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Happiness Development Group Limited (HAPP) trades at $4.50. Happiness Development Group Limited focuses on the research, development, manufacture, and sale of nutraceutical and dietary supplement products. Market cap: $31.3M, Sector: Consumer defensive.

Last analyzed: Mar 18, 2026
Happiness Development Group Limited focuses on the research, development, manufacture, and sale of nutraceutical and dietary supplement products. It also provides e-commerce and automobile sales platform services in China and internationally.

Analyst Coverage for HAPP: HAPP does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates HAPP against Consumer Defensive peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.

Watch the HAPP film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bearish Lean 26/100 · F

HAPP: 2/2 scored disciplines lean bearish. Dominant signal: Seth Klarman bearish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Izzy Englander
Neutral
Seth Klarman
Bearish
Moon AI
Neutral
Munger's Mindset · Balance Sheet & Valuation
Financial Health
Weak
Margin of Safety
Fairly Valued
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Happiness Development Group Limited (HAPP) Consumer Business Overview

CEOXuezhu Wang
Employees218
HeadquartersNanping, CN
IPO Year2019

Happiness Development Group Limited, operating in the consumer defensive sector, develops, manufactures, and sells nutraceutical and dietary supplement products, including lucidum spore powders and traditional Chinese herbal extracts, primarily in China. The company also offers e-commerce and automobile sales platform services, diversifying its revenue streams.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 18, 2026

What Is the Investment Thesis for HAPP?

As of Mar 18, 2026 — figures reflect the data available on that date.

Happiness Development Group Limited presents a speculative investment opportunity within the nutraceutical and dietary supplement market in China. The company's diverse product portfolio, including traditional Chinese medicine-based supplements, caters to a growing health-conscious consumer base. However, the company's negative profit margin of -60.4% raises concerns about its financial sustainability. Growth catalysts include expanding its e-commerce platforms and increasing market penetration in the Chinese nutraceutical market. The company's small market capitalization of $31.3M makes it susceptible to volatility. Investors should carefully consider the risks associated with investing in a small-cap company with negative profitability.

Based on FMP financials and quantitative analysis

HAPP Key Highlights

Market capitalization of $31.3M, indicating a small-cap company with potential for high volatility.

  • Negative P/E ratio of -0.17, reflecting current losses and challenging profitability.
  • Profit margin of -60.4%, signaling significant operational inefficiencies or high costs.
  • Gross margin of 4.1%, suggesting limited pricing power and high cost of goods sold.
  • Beta of 0.22, indicating lower volatility compared to the overall market.

Who Are HAPP's Competitors?

HAPP is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
AIU Meta Data Limited $0.61 +2.50% $37.6M 64
CASK Heritage Distilling Holding Company, Inc. $0.60 +23.89% $15.9M 45
CLXT Calyxt, Inc. $6.30 +5.53% $31.3M 43
GEHI Gravitas Education Holdings, Inc. $13.23 +5.78% $18.3M 38
ZHYBF Zhong Yuan Bio-Technology Holdings Limited $2.02 +0.00% $35.8M 64
JVA Coffee Holding Co., Inc. $3.52 +0.57% $20.1M 74
BRCNF Burcon NutraScience Corporation $1.35 -2.88% $17.1M 59
BUBSF Bubs Australia Limited $0.08 +0.00% $69.2M 53

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are HAPP's Key Strengths?

Established brand presence in the Chinese nutraceutical market.

  • Diversified product portfolio including traditional Chinese medicine-based supplements.
  • Multiple revenue streams from nutraceuticals, e-commerce services, and automobile sales platform.
  • Existing distribution network through various retail channels.

What Are HAPP's Weaknesses?

Negative profit margin and low gross margin, indicating financial challenges.

  • Small market capitalization, making it susceptible to volatility.
  • Limited international presence, relying primarily on the Chinese market.
  • Dependence on regulatory approvals for its nutraceutical products.

What Could Drive HAPP Stock Higher?

Potential regulatory approvals for new nutraceutical products, expanding the product portfolio.

  • Expansion of the Happy Buy e-commerce platform to attract more vendors and customers.
  • Increasing health awareness and disposable incomes in China, driving demand for nutraceuticals.

What Are the Key Risks for HAPP?

Negative return on equity (-62.5%) — the business is not currently generating profit on shareholder capital.

  • Intense competition from established domestic and international players in the nutraceutical market.
  • Stringent regulatory requirements and potential changes in regulations affecting the industry.
  • Fluctuations in raw material prices and supply chain disruptions impacting profitability.
  • Negative profit margin and low gross margin, raising concerns about financial sustainability.

What Are the Growth Opportunities for HAPP?

  • Expansion of E-commerce Platforms: Happiness Development Group can leverage its Happy Buy platform to expand its reach to a wider customer base in China. The e-commerce market in China is massive and growing, providing a significant opportunity for the company to increase sales and brand awareness. Investing in marketing and technology to enhance the platform's user experience and attract more vendors could drive substantial growth.
  • Increased Market Penetration in Nutraceuticals: The Chinese nutraceutical market is experiencing significant growth due to rising health awareness and disposable incomes. Happiness Development Group can focus on increasing its market share by introducing new products, expanding its distribution network, and strengthening its brand presence. Targeted marketing campaigns and collaborations with healthcare professionals can help to educate consumers about the benefits of its products. The nutraceutical market in China is expected to continue growing at a rapid pace, providing a favorable environment for the company's growth.
  • Strategic Partnerships with Retailers: Collaborating with large-scale chain drugstores, malls, and supermarkets can provide Happiness Development Group with access to a broader customer base and enhance its distribution capabilities. Strategic partnerships can also help the company to increase its brand visibility and credibility. Negotiating favorable shelf space and promotional opportunities can drive sales and market share. These partnerships can be particularly effective in reaching consumers who prefer to purchase nutraceuticals in physical stores.
  • Product Innovation and Diversification: Investing in research and development to create new and innovative nutraceutical products can help Happiness Development Group to differentiate itself from competitors and attract new customers. Diversifying its product portfolio to include products targeting specific health concerns or demographics can also expand its market reach. Focusing on developing products with scientifically proven benefits and high-quality ingredients can enhance the company's reputation and brand loyalty. The company can also explore developing products that cater to the growing demand for personalized nutrition.
  • Expansion into International Markets: While currently focused on the Chinese market, Happiness Development Group can explore opportunities to expand its operations into other international markets with a growing demand for nutraceuticals. Identifying markets with similar consumer preferences and regulatory environments can facilitate a smoother entry. Adapting its products and marketing strategies to suit local tastes and preferences can increase its chances of success. International expansion can provide the company with new revenue streams and reduce its reliance on the Chinese market.

What Are HAPP's Competitive Advantages?

  • Brand recognition in the Chinese nutraceutical market under the 'Happiness' brand.
  • Established distribution network through distributors, drugstores, malls, and supermarkets.
  • Diversified revenue streams from nutraceuticals, e-commerce services, and automobile sales platform.
  • Proprietary formulations and manufacturing processes for its nutraceutical products.

What Does HAPP Do?

Founded in 2004 and headquartered in Nanping, China, Happiness Development Group Limited, formerly known as Happiness Biotech Group Limited until October 2022, operates within the consumer defensive sector, specifically focusing on packaged foods. The company researches, develops, manufactures, and sells a range of nutraceutical and dietary supplement products. These products include lucidum spore powders, cordyceps mycelia, Ejiao products, American ginseng products, other traditional Chinese herbal and animal extracts, vitamins, minerals, and amino acids. Happiness Development Group distributes its products through various channels, including distributors, large-scale chain drugstores, malls, and supermarkets, under the 'Happiness' brand. Beyond its core nutraceutical business, Happiness Development Group also offers product marketing and e-commerce agency operation services through the Happy Buy platform, targeting small and middle-size businesses. Additionally, the company provides e-commerce solutions, internet information, and advertising services to online stores and manufacturers. The Taochejun automobile sales platform provides a secure transaction environment, automobile procurement, and financial services for automobile manufacturers, further diversifying the company's operations and revenue streams. The company employs 218 people.

What Products and Services Does HAPP Offer?

  • Researches and develops nutraceutical and dietary supplement products.
  • Manufactures lucidum spore powders, cordyceps mycelia, and Ejiao products.
  • Sells American ginseng products and other traditional Chinese herbal extracts.
  • Offers vitamins, minerals, and amino acid supplements.
  • Provides product marketing and e-commerce agency operation services via the Happy Buy platform.
  • Delivers e-commerce solutions, internet information, and advertising services.
  • Operates the Taochejun automobile sales platform, offering secure transactions and financial services.
  • Sells products through distributors, drugstores, malls, and supermarkets under the Happiness brand.

How Does HAPP Make Money?

  • Develops and manufactures nutraceutical and dietary supplement products.
  • Generates revenue through the sale of these products via various distribution channels.
  • Offers e-commerce and marketing services to small and medium-sized businesses.
  • Provides automobile sales platform services, generating revenue through transaction fees and related services.

What Industry Does HAPP Operate In?

Happiness Development Group Limited operates in the packaged foods industry, specifically within the nutraceutical and dietary supplement segment. The Chinese market for nutraceuticals is experiencing growth, driven by increasing health awareness and disposable incomes. However, the market is also highly competitive, with numerous domestic and international players. Happiness Development Group faces competition from established brands and must differentiate itself through product innovation, marketing, and distribution strategies. The industry is also subject to regulatory scrutiny, requiring companies to comply with stringent quality and safety standards.

Who Are HAPP's Key Customers?

  • Health-conscious consumers seeking nutraceutical and dietary supplements.
  • Small and medium-sized businesses utilizing the Happy Buy platform for e-commerce and marketing services.
  • Online stores and manufacturers seeking e-commerce solutions and advertising services.
  • Automobile manufacturers using the Taochejun platform for sales and financial services.
AI Confidence: 69% Updated: Mar 18, 2026

How Happiness Development Group Limited Is Valued

Happiness Development Group Limited carries a market capitalization of $31.3M, placing it in the micro-cap category.

Company Profile

Happiness Development Group Limited operates in the Packaged Foods industry within the Consumer Defensive sector. It is headquartered in Nanping, CN. The company is led by CEO Xuezhu Wang. HAPP has traded publicly since 2019.

ROE -62%

Key Financial Metrics

Return on equity for Happiness Development Group Limited stands at -62.5%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -55.4%, showing how much profit it generates from its asset base. Its free cash flow yield is -97.6%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.15 indicates the company holds enough short-term assets to cover its near-term obligations.

F-Score 6/9

Financial Health

Happiness Development Group Limited's Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.

HAPP Financials

Fundamental Snapshot

Return on Equity (TTM)
-62.5%
Current Ratio
3.2

Based on FMP financials and quantitative analysis

Bull Case vs Bear Case

Bull Case

  • Established brand presence in the Chinese nutraceutical market.
  • Diversified product portfolio including traditional Chinese medicine-based supplements.
  • Multiple revenue streams from nutraceuticals, e-commerce services, and automobile sales platform.
  • Existing distribution network through various retail channels.

Bear Case

  • Negative profit margin and low gross margin, indicating financial challenges.
  • Small market capitalization, making it susceptible to volatility.
  • Limited international presence, relying primarily on the Chinese market.
  • Dependence on regulatory approvals for its nutraceutical products.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026

HAPP Latest News

No recent news available for HAPP.

Leadership: Xuezhu Wang

CEO

Xuezhu Wang is the CEO of Happiness Development Group Limited. Information about Mr. Wang's prior experience and educational background is not available in the provided data. As CEO, he is responsible for overseeing the company's overall strategy, operations, and financial performance. He manages a team of 218 employees and is tasked with driving growth and profitability in the competitive nutraceutical and dietary supplement market.

Track Record: Due to the limited information available, it is difficult to assess Xuezhu Wang's track record. However, since becoming CEO, he has overseen the company's operations in the nutraceutical and e-commerce sectors. The company changed its name from Happiness Biotech Group Limited to Happiness Development Group Limited in October 2022 under his leadership. Further information is needed to evaluate his specific achievements and strategic decisions.

Happiness Development Group Limited Consumer Defensive Stock: Key Questions Answered

What happened to Happiness Development Group Limited (HAPP) stock?

Happiness Development Group Limited (HAPP) no longer trades on public markets. It was delisted in March 2023. The figures below are historical and are not a current quote.

Can I still buy HAPP shares?

No. HAPP stopped trading on public markets in March 2023, so the shares are not available through a broker. Anything you see quoted for HAPP elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before HAPP stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Happiness Development Group Limited. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

What does Happiness Development Group Limited do?

Happiness Development Group Limited engages in the research, development, manufacture, and sale of nutraceutical and dietary supplement products in China and internationally. Its product range includes lucidum spore powders, cordyceps mycelia, Ejiao products, and American ginseng products. The company also operates the Happy Buy platform, providing e-commerce and marketing services to small and medium-sized businesses.

What are the main risks for HAPP?

The main risks for Happiness Development Group Limited include intense competition in the nutraceutical market, stringent regulatory requirements, fluctuations in raw material prices, and supply chain disruptions. The company's negative profit margin and low gross margin pose significant financial challenges. Its small market capitalization makes it susceptible to volatility.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • Limited financial data available for in-depth analysis.
  • Lack of analyst coverage restricts assessment of market sentiment.
  • Information on CEO track record is limited.
Data Sources

Popular Stocks

More Stocks We Cover